Antibody-Dependent Cell-Mediated Cytotoxicity Overcomes NK Cell Resistance in <i>MLL</i> -Rearranged Leukemia Expressing Inhibitory KIR Ligands but Not Activating Ligands
Wing Keung Chan(The Ohio State University), Wing Leung(KK Women's and Children's Hospital), Jonathan Zalevsky(Nektar Therapeutics (United States)), Sarah Schell(St. Jude Children's Research Hospital), Ying Li(Hebei Medical University), May Kung Sutherland(Seagen (United States))
Cited by 37
Related Papers
β-Arrestin–Dependent Endocytosis of Proteinase-Activated Receptor 2 Is Required for Intracellular Targeting of Activated Erk1/2
|The Journal of Cell Biology|2000|816
Enhanced antibody half-life improves in vivo activity
|Nature Biotechnology|2010|654
NKAML: A Pilot Study to Determine the Safety and Feasibility of Haploidentical Natural Killer Cell Transplantation in Childhood Acute Myeloid Leukemia
|Journal of Clinical Oncology|2010|648
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
|The Lancet Oncology|2010|586
Extended Follow-up of Long-Term Survivors of Childhood Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2003|453